1. HBW Insight

Ending Drug Ingredient Animal Tests Gains Steam In US Due To Unreliable Human Toxicity Predictions

 
• By Eileen Francis

Researchers testing OTCs, supplements and cosmetics seek in vitro test alternatives as animal toxicity tests aren’t strong indicators for humans, says consultant John Harbell. At CHPA conference, he says half of drug failures in clinical trials are due to toxicity in humans despite animal tests showing safety.

Small experimental mouse is on the laboratory researcher's hand

Toxicity testing with animals still is used for many OTC drug, dietary supplement and cosmetic ingredients even though the results often don’t extrapolate to humans. That failure, says toxicology and product safety consultant John Harbell, is leading industry and US regulators to accelerate their search for testing alternatives.

Speaking during the Consumer Healthcare Products Association’s Regulatory, Scientific & Quality Conference on 1 September, Harbell suggested the drive in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

More from HBW Insight

‘Off-Label’ Beauty Hacks: Navigating the Risks of Consumer-Driven Innovation

 
• By Rachel Raphael, Elizabeth Bresnahan and Kathryn Ignash

Guest authors Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP and associates at the firm, Elizabeth Bresnahan and Kathryn Ignash, advise beauty companies on how to navigate the legal risks associated with consumers ‘off-label’ beauty hacks.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By Tom Gallen

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

US Adverse Event Report Forms Replace ‘Gender’ Options With Male Or Female ‘Sex’ Question

Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.